Here’s how experts said they would respond to injuries like Trump’s — and their thoughts on the lingering questions that have ...

It's much less likely that cancer patients who are racial minorities find the perfect match for a bone marrow transplant. A ...

Elevance said the amount of care its Medicaid members are getting is outpacing what states are paying the insurer to cover ...

With resignations of top leaders, Cassava Sciences exposes a dark, ugly corner of the Alzheimer’s disease world, ...

A clutch of headlines last week suggested the U.S. Senate had achieved a breakthrough in the battle to prevent pharmaceutical ...

Gilead Sciences’ chief medical officer will leave the company early next year as the drugmaker struggles to find new areas of ...

Roche reported positive early data from an obesity drug candidate, bolstering the case it could become a player in the ...

It makes no sense that OB-GYN physicians should have to travel to Texas, a state with restrictive abortion laws, to take an ...

Shares of Alnylam have been riding high since the biotech last month reported positive results from its pivotal HELIOS-B ...